Sema4, an interdisciplinary health information company focused on empowering people to take charge of their health and data, announced the launch of CarrierCheck, a simple saliva-based test that provides individuals with a snapshot of how their DNA may affect their future children.

Formerly the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai, Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking

CarrierCheck, the only carrier test that screens for 67 conditions that can be ordered by consumers online, was developed in collaboration with Helix, a personal genomics company that has launched the first online marketplace for DNA-powered products.

While many companies, including Sema4, currently offer physician-ordered carrier screening tests, CarrierCheck stands apart in providing individuals with an online ordering pathway to a genetic test with easy-to-understand results that can reveal an individual's probability of being a carrier for any of the 67 hereditary conditions tested including cystic fibrosis, sickle cell disease, and polycystic kidney disease.

Helix's proprietary technology, called Exome+, reads every letter of all 22,000 protein-coding genes in your body, which produces 100 times more data than most consumer genetics companies. CarrierCheck is available to purchase for $199 plus a one-time cost of $80 for the Helix DNA kit for new customers.